CAS 40958-31-4

Somatostatina (reducida de oveja)

Descripción:

La somatostatina (reducida de oveja), con el número CAS 40958-31-4, es una hormona péptida que desempeña un papel crucial en la regulación de varios procesos fisiológicos. Se conoce principalmente por sus efectos inhibitorios sobre la secreción de otras hormonas, incluyendo la hormona del crecimiento y la insulina, influyendo así en el crecimiento y las funciones metabólicas. Esta forma de somatostatina se deriva de ovejas y se caracteriza por una secuencia específica de aminoácidos que la distingue de otras variantes. La molécula exhibe típicamente una estructura cíclica, lo que contribuye a su estabilidad y actividad biológica. La somatostatina actúa a través de receptores específicos, lo que lleva a una variedad de efectos como la modulación de la neurotransmisión y la regulación de la actividad gastrointestinal. Sus aplicaciones terapéuticas incluyen el tratamiento de la acromegalia, ciertos tipos de tumores y trastornos gastrointestinales. En general, la somatostatina (reducida de oveja) es significativa tanto en la regulación fisiológica como en las aplicaciones clínicas, destacando su importancia en endocrinología y farmacología.

Fórmula: C₇₆H₁₀₆N₁₈O₁₉S₂

InChI: InChI=1S/C76H106N18O19S2/c1-41(79)64(100)82-37-61(99)83-58(39-114)73(109)85-50(27-15-17-29-77)65(101)89-56(35-60(80)98)70(106)87-52(31-44-19-7-4-8-20-44)67(103)86-53(32-45-21-9-5-10-22-45)68(104)88-55(34-47-36-81-49-26-14-13-25-48(47)49)69(105)84-51(28-16-18-30-78)66(102)93-62(42(2)96)74(110)90-54(33-46-23-11-6-12-24-46)71(107)94-63(43(3)97)75(111)91-57(38-95)72(108)92-59(40-115)76(112)113/h4-14,19-26,36,41-43,50-59,62-63,81,95-97,114-115H,15-18,27-35,37-40,77-79H2,1-3H3,(H2,80,98)(H,82,100)(H,83,99)(H,84,105)(H,85,109)(H,86,103)(H,87,106)(H,88,104)(H,89,101)(H,90,110)(H,91,111)(H,92,108)(H,93,102)(H,94,107)(H,112,113)/t41-,42+,43+,50-,51-,52-,53-,54-,55-,56-,57-,58-,59-,62-,63-/m0/s1

Clave InChI: XWJDVNOOYSANGI-ATOGVRKGSA-N

SMILES: C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CC4=CC=CC=C4)NC(=O)[C@H](CC5=CC=CC=C5)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](C)N)O

Sinónimos:

• 12: PN: WO03062429 SEQID: 12 unclaimedsequence
• 147: PN: US20090175821SEQID: 175 claimed protein
• 1702: PN: WO03060071 SEQID: 1726 unclaimed
• 1: PN: CN1372000 PAGE: 1 claimedsequence
• 1: PN: WO2010003939 PAGE: 1 unclaimedsequence
• 1: PN: WO9966950 SEQID: 1 claimed protein
• 37: PN: WO2009150470 PAGE: 36 unclaimedsequence
• 3: PN: WO2009123735SEQID: 3 unclaimed protein
• 456: PN: US20080312157 SEQID: 504 unclaimedsequence
• 61: PN: WO9966952SEQID: 58 unclaimed protein
• 64: PN: WO2008041849 SEQID: 66 claimed protein
• 7: PN: WO0075166 SEQID: 7 unclaimedsequence
• 9: PN: ES2257158 PAGE: 2 unclaimedsequence
• Dihydrosomatostatin
• 9:PN: EP1650566 SEQID: 9 unclaimed sequence
• 1: PN: EP1941902 PAGE: 2 unclaimed sequence
• 1: PN: WO2009157926 SEQID: 1 unclaimed sequence
• 80: PN: US6713301SEQID: 80 unclaimed sequence
• 32: PN:US7074761 SEQID: 32 claimed sequence
• 26: PN: CN1690206 PAGE: 28unclaimed sequence
• 6:PN: CN1366061 PAGE: 4 unclaimed sequence
• 1: PN:WO2009158395 SEQID: 1 unclaimed sequence
• 19: PN:WO0069900 SEQID: 189 unclaimed sequence
• 13: PN: CN1672733 PAGE: 20 unclaimed sequence
• 31: PN: WO0069900 SEQID: 201 unclaimed sequence
• 3: PN: WO2009081170 PAGE: 22 claimed sequence
• 1: PN: WO2008081013 PAGE: 1unclaimed sequence
• 5: PN: WO0069900 SEQID: 175 unclaimed sequence
• 6: PN: WO2008004992 SEQID: 29unclaimed sequence
• 1: PN: US6183722 SEQID:1 unclaimed sequence
• 9: PN: WO0114888 SEQID: 7 unclaimed sequence
• 23: PN:WO2005003296 SEQID: 294 unclaimed sequence
• 1: PN: US6214316 SEQID: 1 unclaimed sequence
• 12: PN:US20010025097 SEQID: 3 claimed sequence
• 21: PN: CN1690207 PAGE: 25unclaimed sequence
• 804: PN: WO03059934 SEQID: 650 unclaimed sequence
• 98: PN: WO02077036 PAGE: 55 claimed sequence
• 1: PN:WO2004080483 FIGURE: 2 unclaimed sequence
• 235: PN: WO2009103965 PAGE: 10 unclaimed sequence
• 77: PN:WO9966957 SEQID: 80 claimed sequence
• 70: PN: US20080213898 SEQID: 68 claimed sequence
• Somatostatin【sheep reduced】
• L-Ala-Gly-L-Cys-L-Lys-L-Asn-L-Phe-L-Phe-L-Trp-L-Lys-Thr-L-Phe-L-Thr-L-Ser-L-Cys-OH
• SRIF-14
• reduced somatostatin

Somatostatin-14 (reduced)

CAS: 40958-31-4

Bachem ID: 4025089.

Fórmula: C₇₆H₁₀₆N₁₈O₁₉S₂

Pureza: 98.7%

Forma y color: White

Peso molecular: 1639.92

Ref: 01-4025089

Somatostatin-14 (reduced)

CAS: 40958-31-4

Somatostatin-14 (reduced) (SST 14) is a peptide identified through polypeptide screening, which is a research tool primarily utilizing immunoassay techniques to isolate active polypeptides. This method is applicable in protein interactions, functional analysis, antigen epitope screening, and is particularly relevant in the study and development of active molecules.

Fórmula: C₇₆H₁₀₆N₁₈O₁₉S₂

Forma y color: Solid

Peso molecular: 1639.89

Ref: TM-TP3411

Somatostatin-14 (reduced)

CAS: 40958-31-4

Somatostatin-14 (reduced) H-Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys is a synthetic peptide that is an adjuvant for vaccines. It induces a biphasic response by increasing the humoral immune response and decreasing the cellular immune response. Somatostatin has been shown to decrease the severity of symptoms in patients with psychiatric disorders and can be used as a long term treatment for these conditions. Somatostatin also has effects on the pancreas, such as inhibiting insulin release, leading to decreased blood glucose levels. Its disulfide bond in its structure may be important for its activity and stability.

Fórmula: C₇₆H₁₀₆N₁₈O₁₉S₂

Pureza: Min. 95%

Peso molecular: 1,639.9 g/mol

Ref: 3D-FS109331